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Author’s response to comments from reviewer 1 
 
1. Provide a checklist or advice for future studies due to level of diversity of the 
research in this area. 
 
We have incorporated advice/guidance into the discussion regarding both the 
direction of future research as well as methodological issues that should be 
addressed in studies in this area (p18).  
 
2. A slightly pedantic point relates to the introduction where if we are going to take 
a global view I think it is more relevant to include domestic exposure to biomass 
fuels as a factor other than smoking and there is a very good recent review on 
this subject by Salvi S and Barnes PJ in the Lancet (2009, 345, 733-743). 
 
We have incorporated details of biomass fuel as a major risk factor for COPD in 
the introduction (p4).  
 
3. There is also some newer prevalence data which suggests the prevalence in 
Europe may be even higher than quoted here with some data suggesting a figure 
of 10% in over forty year olds (Miravitlles M et al. Thorax 2009 (Prevalence of 
COPD in Spain). 
 
We have incorporated prevalence data into the introduction.  We did agree with 
this, that as we are taking considering the global problem of COPD, evidence of 
increasing prevalence is valuable background information to the current review.   
 
4. The authors might wish to comment on how fatigue might need to be addressed 
in this group for there are studies suggesting very high rates of fatigue (Breslin E 
et al. Chest 1998, 114; 958-964). 
 
We have incorporated a recommendation to consider fatigue as part of 
psychological interventions to address reduced quality of life for patients with 
COPD (p19). 
 
5. The potential for benefit from psychological interventions does as mentioned 
above of course reflect in part upon its causation. We also rarely see good studies 
looking at the prevalence of anxiety and depression in a disease compared with 
the rates of a normal population. There is a suggestion in severe COPD that 
depression might be 2.5 times commoner in a matched control (Manen JG et al. 
Thorax 2002, 57; 412-416) but if I recall that study properly leaving alone was a 
significant causative factor. 
 
Response to Reviewers Comments
Issues of causation have been addressed in the concluding paragraph of the 
discussion, with recommendations regarding measurement of psychological 
outcomes in this population (p18).  
 
6. The authors chose to exclude pulmonary rehabilitation studies from their review. 
The availability of pulmonary rehabilitation does vary quite significantly from 
country to country but so presumably does the availability of CBT and other 
psychological interventions. If I did not have either it would be helpful to me to 
know which of those is most likely to be helpful always taking into account that 
pulmonary rehabilitation is also going to help symptoms and has a proven effect 
on quality of life. The discussion could include some further reference to the 
effect of pulmonary rehabilitation on anxiety and depression. 
 
We have referred to reasons for excluding pulmonary rehabilitation as well as 
discussed its effect on anxiety and depression from a recent systematic review 
and meta-analysis in the discussion.  We have talked about its efficacy in the 
light of the reviewers previous comments about the causation of psychological 
morbidity (i.e. relation to physical symptoms (p18). 
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Abstract 
Objective: To systematically evaluate the efficacy of psychologically based interventions for 
addressing psychological outcomes in patients with chronic obstructive pulmonary disease 
(COPD).   
 
Methods: Electronic databases, key journals and reference lists of included studies were 
scrutinised for inclusion; in addition authors were contacted for potential unpublished 
research.  Nine studies were identified for inclusion.  Data was extracted by two reviewers 
independently using a standardised extraction sheet and a series of meta-analyses completed 
for measures of anxiety, depression and quality of life. 
 
Results: Eight studies evaluated a cognitive behavioural- or psychotherapeutically-based 
intervention and one study evaluated taped progressive muscle relaxation.  The studies 
revealed some evidence for the interventions’ impact on anxiety, but, taken together 
interventions had limited effectiveness.  The meta-analyses that were conducted revealed a 
small effect for anxiety only. 
 
Conclusion:  The results are discussed considering the limitations of the research and 
previous work in this area.  A systematic evaluation of psychological interventions on 
psychological co-morbidity in patients with COPD is recommended. 
 
Practice Implications:  There is some evidence that psychological interventions impact 
anxiety and this should be explored further and more interventions should target quality of 
life. 
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1.  Introduction  
Chronic obstructive pulmonary disease (COPD) is a preventable respiratory condition 
characterised by progressive and irreversible airflow obstruction.  Tobacco use has 
traditionally been cited as the primary risk factor for COPD [1] but a recent review of 
COPD in non-smokers has revealed exposure to biomass fuels may be a more significant 
risk factor [2].  In the UK, COPD prevalence is reported at rates between 2% to 4% with 
general practices reporting prevalence at levels from 0% to 7.4% [3].  More recently 
prevalence has been reported as high as 10.2% in Spain [4].  COPD is reported to cost the 
NHS £800 million per annum with a further loss of 24 million working days and 30,000 
deaths per annum [5].  The disease is currently rated as the fourth leading cause of death 
worldwide, and is projected by the World Health Organisation (WHO) to increase to the third 
most likely cause of death by 2020 due to the continuation of, and increased exposure to, risk 
factors and the increasing age of the population [6].      
 
In addition to disabling physical symptoms, such as breathlessness, chronic cough and 
sputum production, a large proportion of patients also experience psychological distress [7].  
Anxiety and depression are common; a systematic review and meta-analysis reported the 
prevalence of clinically significant anxiety and depression as approximately 36% and 40%, 
respectively [8].  There is also evidence that quality of life is significantly reduced in patients 
with COPD [9].  These psychological outcomes appear to be linked with the physical 
manifestations of the disease; for example breathlessness can precipitate anxiety, and vice 
versa [10].   
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Despite the wealth of literature highlighting the problems of anxiety, depression and quality 
of life in COPD, medical management has focused on the physical characteristics of the 
disease [11].  This focus is reflected in the current treatment guidelines [1], despite evidence 
that patients exhibiting symptoms of psychological distress are at increased risk of relapse, 
re-admission and use disproportionately high levels of resources [12].   There is also evidence 
that COPD may be inadequately managed [13].  Less than 30% of treatment providers have 
been reported to follow treatment guidelines for the management of anxiety and depression in 
COPD [14].  Pulmonary rehabilitation is commonly accepted as effective for patients with 
COPD [15; 16; 17], but anxiety and depression can lead to a reduction in engagement with it 
[18; 19].  Further, it has been recommended that the priority in COPD treatment should be 
optimising quality of life as the disease process is irreversible [20]; patients with COPD have 
a reduced quality of life exceeding that expected by disease severity or co-morbid medical 
illness [21].  Interventions targeting psychological distress can be expected to result in 
improvements in quality of life [22].   
 
The efficacy of psychologically based interventions to reduce anxiety and panic in patients 
with COPD has been reviewed [23].  Rose et al (2002) concluded that the evidence, including 
randomised control trials, was insufficient and not of quality to enable recommendations to 
be made.  However, recent evaluations of cognitive behavioural and psychotherapeutic 
interventions have added to the evidence base in this area [24; 25].  Another recent review 
that focused on cognitive behavioural therapy for anxiety and depression in COPD also 
concluded that further research is needed to determine the efficacy of interventions for this 
patient group.  However this review only included four studies and did not assess quality of 
life [26]. 
Psychological Interventions in COPD Page 6 
The current review systematically examines the evidence concerning the efficacy of 
psychologically based interventions to improve anxiety, depression and quality of life in 
patients with COPD.  It aims to ascertain the range of psychologically based interventions 
available for addressing anxiety, depression and quality of life in patients with COPD outside 
of comprehensive pulmonary rehabilitation interventions.  Secondly it aims to assess the 
effectiveness of interventions in improving psychological outcomes for COPD patients 
suffering from psychological co-morbidity.   
 
2. Methods 
2.1 Search Protocol and Inclusion/Exclusion of Studies 
Comprehensive searches of the following health and psychology databases were conducted to 
identify research studies for inclusion up to September 2009: Blackwell Synergy, Index to 
Theses, PsycARTICLES, PsycINFO, Web of Science, Cochrane Library and Medline.  The 
contents lists for the preceding five years of key journals were reviewed online: Thorax, 
Chest, European Respiratory Journal, Journal of Patient Education & Counseling, American 
Journal of Respiratory Critical Care Medicine and COPD: Journal of Chronic Obstructive 
Pulmonary Disease.  In addition, reference lists of included studies and previous reviews 
were scrutinised for additional studies.  Key authors were contacted to obtain details of 
relevant unpublished studies in an attempt to address publication bias.  Disease terms 
(‘chronic obstructive pulmonary/airways disease’, ‘COPD’, ‘COAD’, ‘chronic bronchitis’, 
‘respiratory disease’, ‘emphysema’) were combined with terms relating to psychological 
outcomes (‘depress*’, ‘anxi*’, ‘panic’, ‘(health related) quality of life’, ‘health status’, 
‘HRQOL’, ‘QOL’) and interventions (‘stress management’, ‘relax*’, ‘cognitive 
behavioural/behavioral therapy’, ‘CBT’, ‘psychotherapy’, ‘education’, ‘psychological 
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intervention’) using a standardised protocol utilising Boolean commands to identify the most 
relevant literature.  Where possible, searches were limited to human adult populations.  The 
search protocol was piloted and minor changes made prior to the final systematic search.   
 
English language studies detailing an evaluation of a psychologically based intervention 
aimed at reducing anxiety and/or depression and/or improving (health related) quality of life, 
for patients with a confirmed diagnosis of COPD on spirometry were included.  Papers were 
excluded if they did not contain a psychological component to the intervention or if the 
research population had co-morbidities of asthma or other significant health problems that 
might impact on their ability to engage with psychological interventions.  Papers evaluating 
PR were excluded since this would duplicate existing work.  Electronic database searches of 
study titles identified 15,772 possible studies that were filtered through the search process 
summarised in figure 1.  No additional studies were identified from the contents of key 
journals.  21 studies were initially included for review.  13 were excluded because they: 
failed to evaluate an intervention or contained no psychological component to intervention 
(n=3); were PR (n=2); had inappropriate outcomes (n=1); had duplication of participants 
from other included studies (n=2); were detailed in abstracts from conference proceedings 
(n=3); had no confirmation of COPD diagnosis (n=1); and had inclusion of patients with 
other respiratory disease (n=1) [24; 25; 27-37].  One study was identified from the reference 
list of included studies.  Nine studies were included in the review and meta-analyses (table 1) 
[38-46].         
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2.2 Quality Assessment 
All included studies were subjected to a quality assessment to estimate potential bias that 
could result from combining studies of varying methodological quality, which might lead to 
misleading conclusions [47].  Quality criteria were developed based on recommendations 
made elsewhere [48; 49].  Each study was assessed according to: clear aims, randomisation 
techniques, concealment of treatment allocation, comparability of groups at baseline, blinding 
of interventionists and participants, eligibility for intervention assessed, description of 
intervention provided to allow replication, attrition, effect size, details of long term follow up 
and sustained change, analysis of confounding variables, power analysis, definition of all 
outcomes, measured with reliable measurement tools and results provided for each, and 
appropriate statistical analysis. A score of 0-2 was awarded for each item (0 = no detail, 1 = 
partial detail, 2 = full and adequate detail): these were summed to create a score between 0 
and 52.  All studies included a pre- post- comparison.  Studies did not have to report 
differences between intervention and comparator (control) groups, but this would have been 
reflected in the quality assessments.   
 
2.3 Data extraction 
Data was extracted using a standardised extraction sheet.  A second reviewer (DS) 
independently extracted data from 50% of included studies to ensure accuracy and reliability, 
with reviewers meeting to confirm agreement of extraction and establish reliability.  There 
were no discrepancies reported between the reviewers.  Three studies were excluded by both 
reviewers: one study failed to confirm diagnosis of COPD with spirometry [27]; two studies 
included participants whose data was already reported in another included study [24; 25].  
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Nine studies were included overall and form the basis of this review comprising seven 
published research studies and one unpublished study. 
 
2.4 Data Analysis & Synthesis 
The included studies reported similar research aims but utilised a variety of outcome 
measures and research designs.  All nine studies made some measure of anxiety, eight 
measured depression, and five measured quality of life either as a generic or disease specific 
measure or both.  Descriptive analysis and meta-analysis were carried out for each outcome 
measure.   
 
3.  Results 
 
3.1 Participants 
All nine studies utilised a clinical population of patients with a confirmed diagnosis of COPD 
on spirometry.  Four studies included patients with moderate to severe COPD [40; 41; 42; 
43] and one study included patients with mild to severe COPD [44].  The remaining four 
studies confirmed diagnosis with spirometry, but did not report disease severity [38; 45; 46].  
The mean age of participants ranged from 66 years [44] to 71 years [38].  Five studies were 
conducted in the USA [38; 39; 41; 45; 46], three were conducted in the UK [41; 42; 44] and 
one was conducted in Brazil [40].  The prevalence of male participants ranged from 31% [45] 
to 96.2% [39].  Existing psychological morbidity was reported in six studies although the 
level of detail provided was variable.  One study reported the prevalence of anxiety or 
depression in the study population as 62.2% [39], three studies reported the level of anxiety 
or depression less specifically detailing: mild anxiety and depression amongst the sample 
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[38], the impact of anxiety and depression as mild to moderate [40] or that there was a burden 
of anxiety and depression at baseline [42].  One study found 60% of participants could be 
reported as a probable psychiatric case [44].  One study set out to address clinically 
significant anxiety in patients with COPD, and high levels of anxiety were noted in this study 
[41].  Three studies did not report on baseline existing psychological morbidity [43; 45; 46].     
 
3.2 Aims 
Each of the included studies detailed the aims and objectives of the research, and aimed to 
evaluate the efficacy of an intervention.  The measures used to assess outcomes varied 
although all had been psychometrically tested.  The aims of the studies included: improving 
anxiety, depression physical functioning and quality of life in older patients [38], improving 
anxiety, depression disease specific and generic quality of life, physical functioning, health 
service use in patients with moderate-severe anxiety and/or depressive symptoms [39], 
improving anxiety, depression, quality of life and exercise capacity in patients enrolled in PR 
[40], improving anxiety, quality of life, dyspnoea and exercise tolerance in patients with 
moderately severe COPD [41], assessing the change in levels of disability and cognitive 
distortion and improving anxiety, depression, somatic symptoms and hostility [43],  
improving anxiety, depression and relieving dyspnoea in patients with disability attributable 
to dyspnoea [44], and improving anxiety and dyspnoea [45].  One study examined the effect 
of a nurse administered intervention for patients with varying disease severity [42].  One 
study assessed changes in psychological and cognitive outcomes with a trial of exercise, with 
a comparator of education and stress management [46].  Four studies predicted that the 
psychological intervention would have a positive effect on psychological outcomes by 
reducing anxiety and depression and improving quality of life, [38; 44; 45; 46;], one study 
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predicted that a psychological intervention would be of greater benefit than a non-
psychological intervention [39] and four studies did not hypothesize as to the direction of 
effect [40; 41; 42; 43]. 
 
3.3 Study Design 
The nine studies included 523 participants; 270 were exposed to a psychological intervention.  
Participants were mainly recruited through medical clinics or lists [38; 39; 40; 42; 44; 45].  
One study used a variety of recruitment methods including advertising, physician referral and 
support groups [46].  One study did not make it clear where the participants were recruited 
from [43] and one study did not report sampling methods [41].   
 
Four studies were described as randomized controlled trials (RCT) [38; 39; 40; 46] and two 
studies reported that randomisation methods were used to allocate participants to intervention 
and comparator groups [44; 45].  The remaining studies did not employ any randomisation 
methods [41; 42; 43].  One study used matched controls [41].  Two studies had a control 
group where participants received no intervention but were required to attend to complete 
outcome measures [41; 45].  Three studies made comparisons with participants engaged in a 
different intervention: two studies compared CBT to an education alone intervention [38; 39] 
and one study evaluated the added value of psychotherapy to PR and exercise [40].  Finally, 
one study had four comparison groups looking at three different styles and deliveries of 
psychotherapy and compared these to a control group [44].  Three studies incorporated a 
second, longer term follow-up (3 to 12 months) of patients [39; 41; 44]. 
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3.4  Interventions 
Six studies evaluated cognitive behavioural based therapies: three interventions employed 
group cognitive behavioural therapy (CBT) [38; 39; 41], one employed individual CBT [42] 
and two used a CBT based education intervention [44; 46].  Two studies utilised individual 
psychotherapy [40; 44] and one study used taped progressive muscle relaxation training [45].  
The cognitive behavioural interventions were delivered over varying time frames, from a 
single two-hour intervention [38] to eight weekly sessions [39; 43].  The individual CBT was 
delivered weekly until the therapist and patient felt progress had been made, with a mean 
number of sessions of four (range 2-13) [42].  Individual psychotherapy sessions were offered 
over eight weeks [44] or twelve weeks when part of a PR programme [40].  The progressive 
muscle relaxation programme consisted of four weekly sessions.   
 
Two CBT interventions were delivered by psychiatrists [38; 41], one by a clinical 
psychologist [46], one by psychology interns and post doctoral fellows [39], and one by a 
nurse [42].  The final CBT intervention was delivered by the author of the paper but their 
clinical role was unclear [43].  One psychotherapy intervention was delivered by a 
psychologist [40].  The other psychotherapy intervention included three intervention groups 
whereby supportive and analytic psychotherapy was delivered by a psychotherapist, but a 
comparator intervention included nurse administered therapy although the nurse had not 
received any training in psychotherapy [44].  The progressive muscle relaxation was a taped 
intervention [45].  Six of the interventions were delivered at a medical clinic or physician’s 
office [38; 41; 42; 44; 45; 46]; the remaining studies did not specify a venue. 
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3.5 Quality Assessment of Included Studies 
A number of methodological factors were assessed for quality (table 2).  Adequate 
randomisation procedures were utilised in four studies, using a random number table [38; 
46], randomisation blocks and flipping of a coin [39] and sealed labels assigned to patients 
off the waiting list [44].  Quality scores for randomisation methods of the remaining studies 
varied depending on whether a control group was utilised and how clear these procedures 
were reported.  One study reported on treatment allocation concealment [46].  Due to the 
nature of the remaining studies, interventionists could not be blinded to the treatment 
allocation of participants.  Only one study made an attempt to control for this through using 
the same interventionists to provide the psychological and control interventions [39].  Six 
studies ensured participants were blinded to the nature of the study and put adequate steps in 
place [38; 39; 40; 44; 45; 46].  Three studies reported that the assessor was blind to treatment 
allocation [40; 44; 46]; the remaining studies providing no details regarding blinding.  Seven 
studies utilised a comparator group [38; 39; 40; 41; 44; 45; 46], and each of these provided 
details of the treatment of control participants.  Six of the seven studies reported that the 
groups were comparable at baseline [38; 39; 40; 44; 45; 46].  In the remaining study, the 
intervention had significantly higher prevalence of anxiety than the control group and so 
comparisons between these groups could not be made for anxiety outcome measures [41].   
 
Attrition rates were reported and analysis performed concerning the differences between 
groups for three studies [39; 45; 46].  Partial details were given for a further five studies but 
analysis of differences could not be completed [38; 41; 42; 43; 44].  From the data that was 
extracted, 201 participants were lost from 364 assigned participants due to: not wanting to 
participate, medical reasons, time constraints, transport problems, no interest, financial 
Psychological Interventions in COPD Page 14 
distress, non-attendance, unable to complete and inability protocol.  Only one study 
conducted an a priori power analysis to determine the number of participants required in the 
study to achieve a required effect size [39]; the same study was unique in reporting effect 
sizes of change in measured outcomes. 
 
The quality of the interventions was good, with few points lost on assessment.  Details of 
what the interventions were, how they were delivered, and who by were clearly reported for 
each study.  All but one study reported the eligibility criteria for participants to engage with 
the intervention, the remaining study being unclear on these details [42].  All of the 
interventions were sufficiently reported to enable replication.   
 
3.6 Quantitative Analysis 
The studies used similar statistical methods to assess the research questions, specifically 
MANOVA, ANOVA and t-tests, which were judged to be appropriate for the study designs 
utilised (table 2).  One study used Wilcoxon, Mann-Whitney U and Kruskall Wallis analysis 
[44].  Anxiety measures were reported for each study.  Improvement in anxiety scores was 
reported in four studies when comparing pre- and post-intervention scores within the groups 
[38; 39; 40; 42], but was not confirmed in three studies [41; 43; 46].  Long term follow up of 
change was reported in one study, finding a sustained improvement in anxiety scores within 
groups at 44 weeks post intervention [39].  One study reported mixed results with significant 
improvement on one measure of general psychological health but anxiety increased 
significantly for the supportive psychotherapy group and decreased significantly for the 
control group, with analytic and nurse psychotherapy groups remaining unchanged [45].  A 
significant interaction was found between the relaxation and control groups, with anxiety 
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reducing significantly in the relaxation group and remaining stable in the control group [45].    
One study did not show improvement over the comparator group [39] and comparison 
between groups could not be made for one study as the groups were not comparable at 
baseline with regard anxiety scores [41]. 
 
The seven studies that assessed depression found mixed results.  Four studies reported a 
statistically significant improvement in depression scores when comparing pre- and post 
intervention scores [38; 39; 40; 42], but analysis between intervention and comparator 
groups were not significantly different [39].  Only one study assessed long term follow up of 
depression scores finding within group changes were maintained at 44 weeks [39].  
Furthermore, two studies did not find within group differences in pre- post-intervention 
scores [43; 46].  Depression scores seemed to increase from baseline to post intervention in 
one study, the greatest increase seen in the analytic psychotherapy group [44]. 
 
Only five studies considered quality of life in the analysis, again producing mixed results.  
Three studies measured generic quality of life [38; 41; 46], one measured disease-specific 
quality of life [40] and one study measured both [39].  Statistical results for quality of life 
outcomes were unclear in some studies as the measure was usually secondary and so detailed 
analysis was not provided.  Two studies revealed significant change on the mental health 
subscale of a generic measure of quality of life measure [38; 39], one of these also reporting a 
significant improvement when the emotional subscales of the measure were amalgamated 
[39].  This improvement was not significant between groups.  A disease specific measure also 
revealed significant improvements in quality of life but these differences were not significant 
between groups [39].  The addition of psychotherapy to PR seemed to significantly improve 
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quality of life in two groups, with no change in the PR alone intervention [40].  Two studies 
measuring generic quality of life found no change in quality of life scores when baseline and 
post intervention scores were compared for within-subjects analysis for intervention or 
control groups [41; 46].  
 
3.7 Meta Analysis 
Six meta-analyses were conducted for within and between group anxiety, depression and 
quality of life.  One meta-analysis based on pre-post intervention anxiety scores of 
intervention group participants from eight included studies (n = 222) revealed a combined 
effect size of r = -0.273 (CI -0.419 to -0.141, p<0.00004), representing a small effect size 
(table 3) [50].  The remaining five analyses revealed four file drawer problems and one 
heterogeneity problem. 
 
4.  Discussion 
The literature evaluating the efficacy of psychological interventions to improve anxiety, 
depression and/or quality of life for patients with COPD is relatively sparse but growing.  
This systematic review identified nine studies for inclusion which compares favourably with 
Rose’s (2002) review (n=6) [23].  The study population predominantly comprised patients 
with moderate-severe disease and with existing morbidity of mild-moderate anxiety and/or 
depression.  Six interventions were based on cognitive behavioural therapy, two interventions 
were based on psychotherapy and one used progressive muscle relaxation training.  None of 
the interventions focused on changing quality of life; it was considered a secondary outcome 
measure.  Mixed results were observed for the efficacy of these interventions across all 
outcome measures of anxiety, depression and quality of life, with results not offering support 
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for psychological intervention.  Meta-analysis revealed a small but significant effect for 
the use of intervention in reducing anxiety but only when compared within groups.  This 
was not significant when compared with a control comparison. 
  
Not all of the included studies reported each psychological outcome of interest: nine studies 
addressed anxiety, seven studies addressed depression and five studies addressed quality of 
life.  Furthermore, the tools used to measure psychological distress were diverse; this was 
particularly true for quality of life measures which were further split into measures of 
disease-specific and generic quality of life.  Two studies did not utilise a comparator group, 
which meant that confounding variables could not be controlled for and any changes in scores 
post intervention could not be attributed to the intervention alone.  Only three studies 
reported measures taken subsequent to the initial post intervention assessment.  Future studies 
should examine long term benefits in addition to initial changes.   
 
The current review indicates that more recent studies are of a higher standard.  However, 
although validated, a variety of measures were used making it difficult to interpret and 
combine the results of the studies.  Therefore, we reiterate previous recommendations that 
psychological interventions must be systematically evaluated through studies of continued 
high methodological quality in order to establish the efficacy of psychological interventions 
in the routine management of patients with COPD [23]. 
 
The results and limitations of the studies included in the current review indicate that future 
research should also include patients with mild to moderate disease and assess the impact of 
basic psychological intervention as part of routine management of patients with COPD on 
Psychological Interventions in COPD Page 18 
their psychological functioning and quality of life.  In the longer term, the effects of routine 
screening for psychological distress and interventions to address psychological outcomes in 
the early stages of disease should be considered.  The included studies in this review did not 
evaluate the cost effectiveness of interventions.  This should be considered to determine 
whether increased active management of psychological morbidity improves outcomes and 
reduces the financial burden to the NHS to a greater value than the cost of intervention.   
 
Interventions that have been shown to be effective in treating anxiety and depression do 
not appear to be effective in reducing psychological morbidity in a COPD population.  
This may be due to the overlap between symptoms of disease and items used to measure 
these psychological outcomes (e.g., there is an overlap between fatigue and depression 
on some questionnaire measures).  Additionally it is possible that aspects of therapy that 
are most effective in reducing these outcomes are not feasible for use in this population 
(e.g. voluntary hyperventilation).  Future research should pay careful attention to the 
measures used in assessing psychological morbidity.  Studies evaluating pulmonary 
rehabilitation were excluded from the current review as this has previously been shown 
to be more effective in reducing anxiety and depression than standard care in moderate 
to severe COPD [21].  As pulmonary rehabilitation also seeks to improve the physical 
functioning of patients, this again could be attributed to improvements in the symptoms 
of COPD such as breathlessness, and this should be addressed in future research.  
Intervention studies should be consistent in using the GOLD guidelines for determining 
the disease severity of patients [6], in selecting robust measures of anxiety, depression 
and quality of life, suitable for use in a COPD population and should aim to evaluate the 
long term benefits of intervention in terms of health outcomes and cost effectiveness. 
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Practice Implications 
The benefit of psychological interventions in the management of patients with COPD remains 
largely unclear with mixed results being reported from studies of varying methodological 
quality.  There was some evidence that psychological interventions impact anxiety in patients 
with COPD.  However, whether this improves engagement with pulmonary rehabilitation has 
yet to be examined.  High quality research is needed in this area to establish the efficacy of 
psychologically based interventions and how they impact upon the management of patients 
with COPD.  Although guidelines recommend some element of psychological treatment 
within the management of COPD [1], it remains unclear what is effective outside of 
pulmonary rehabilitation, which is difficult to make available to all patients due to the 
intensity of the intervention.  Additionally interventions should also target quality of life and 
evaluate their efficacy.  Acceptance based approaches may be useful for these patients [51] as 
well as investigating the usefulness of targeting fatigue which has been associated with 
increased respiratory disease severity, reduced exercise tolerance and quality of life 
[52]. 
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Table 1: Characteristics of Included studies (N=9) 
Study ID 
(& reference) 
 
 
Study Design 
 
Sampling 
Number of participants 
overall & in 
(intervention group).   
Details of comparator 
Characteristics of 
participants 
(age, gender, ethnicity, 
disease severity, 
psychological co-morbidity) 
Intervention 
(what, where, duration, 
replicable, groups, 
individual or other, who 
delivered?) 
Psychological 
outcomes and 
measures 
Study 
quality 
score  
max 50 
 (Kunik, Braun, Stanley, 
Wristers, Molinari, 
Stoebner & Orengo, 2001) 
[38] 
USA 
RCT 
(single blind) 
 
Recruited from 
veterans hospital & 
advertising 
48 (21) 
Comparator group 
education only 
Mean age 71.3, 83% male, 
90% Caucasian, FEV1/FVC 
<70%, mild anxiety and 
depression 
 
 
Cognitive behavioural 
therapy, 2 hour single 
intervention with 6 week 
telephone follow up.  Based 
at medical clinic, groups of 
6-10, replicable. Delivered 
by gero-psychiatrist 
Health related 
quality of life (SF-
36) 
Depression (GDS) 
Anxiety (BAI) 
35 
(Kunik, Veazey, Cully, 
Souchek, Graham, Hopko, 
Carter, Sharafkhaneh, 
Goepfert, Wray & Stanley, 
2007)  [39] 
USA 
RCT 
(single blind) 
 
Recruited from 
veterans hospital & 
advertising 
238 (118) 
Comparator group 
education only 
Mean age 66.3, 96.2% male, 
81% white, mean FEV1/FVC 
57.2%, 62.2% anxiety or 
depression 
Cognitive behavioural 
therapy, 8 x 1 hour sessions, 
weekly basis. Groups of 10.  
Venue not specified, 
replicable, delivered by 
psychology interns, post 
doctoral fellows. 
Disease specific 
QOL (CRQ) 
Generic QOL (SF-
36) 
Anxiety (BAI) 
Depression (BDI-
II) 
36 
(De Godoy, De Godoy, 
Becker Junior, Vaccari, 
Michelli, Teixeira & 
Palombini, 2005) 
[40] 
Brazil 
RCT (single blind) 
 
Consecutive patients 
being treated as 
outpatient, referred 
to PR 
33
1
 (19) 
 
Comparator group PR 
and exercise.  
Age 50yrs+, 73% male, 93% 
Caucasian, mean FVC 66%pr 
(mod-sev disease), mean 
impact of anxiety/dep mild-
moderate  
Individual psychotherapy 
1hr/wk for 12 weeks as part 
of PR. Venue not specified, 
replicable, psychotherapy 
delivered by psychologist 
Anxiety (BAI) 
Depression (BDI) 
Health related 
quality of life 
(SGRQ) 
30 
(Eiser, West, Evans, Jeffers & 
Quirk, 1997)   [41] 
UK 
Repeated measures 
pre-post 
 
Sampling method not 
stated. 
18 (12) 10 participant 
completed and included in 
analysis. Control group 
(n=8) attended weekly for 
outcome measures. 
Mean age 72, 55.5% female, 
50% male: female in intervention 
group, severe but stable COPD, 
sig higher HADS anxiety score 
in treatment than control 
Group based CBT, 6x90 
minute sessions, groups 5-6 
people, replicable, outpatients, 
delivery by psychiatrist. 
Anxiety (HADS) 
Quality of life 
(MRCQ) 
28 
 
                                                 
1
 Includes two groups receiving psychotherapy.  Group 2 excluded as study 4 was based on the same participants as groups 1 & 3, and this data was utilised to 
ensure accuracy of extracted data from study 5. 
Table 1
 
Study ID 
(& reference) 
 
 
Study Design 
 
Sampling 
Number of participants 
overall & in 
(intervention group).   
Details of comparator 
Characteristics of 
participants 
(age, gender, ethnicity, 
disease severity, 
psychological co-morbidity) 
Intervention 
(what, where, duration, 
replicable, groups, 
individual or other, who 
delivered) 
Psychological 
outcomes and 
measures 
(time of 
measurement) 
Study 
quality 
score  
max 50 
 
(Heslop, De Soyza, Baker, 
Stenton & Burns, 
unpublished) 
[42] 
UK 
Repeated measures 
pre-post 
Referred if anxiety/ 
depression felt to be 
contributing to 
symptoms 
 
10 (no comparator group) 
 
Mean age 68 (48-81), 50% male, 
80% severe COPD, 10% mild, 
10% moderate disease, there was 
a burden of anxiety and 
depression at baseline 
Individual cognitive 
behavioural therapy, 
outpatients based, delivered 
weekly, treatment length varied 
according to individual need.  
Nurse delivered, replicable.  
Anxiety (HADS) 
Depression (HADS) 
23 
 
(Lisansky & Clough, 1996) 
[43] 
USA 
Quasi-experimental 
one-group pre-post test 
Self selected 
convenience sample 
8 (no comparator group) Mean age 69.5 (58-83), 62.5% 
women, 37.5% men, moderate-
severe COPD, mean yrs with 
COPD 13.5 (3-40) 
Cognitive behavioural 
education intervention, 8x 
weekly sessions 90 mins Venue 
& interventionist not specified  
Anxiety (SQ Kellner) 
Depression (SQ 
Kellner) 
22 
 
(Rosser, Denford, Heslop, 
Kinston, Macklin, Minty, 
Moynihan, Muir, Rein & Guz, 
1983) [44] 
UK 
Randomised trial 
(blinding not reported) 
Patients screened for 
inclusion  when 
attending respiratory 
clinic 
65 (3 interventions groups 
each with n=16).  
Comparison of analytic or 
supportive psychotherapy, 
nurse administered 
psychotherapy. Also control 
group who had weekly lab 
tests. 
Mean age 66, 68% male, mild-
severe disease severity, mean 
FEV1 0.9, 60% identified as 
probably psychiatric cases 
8x45 minute sessions of 
analytic, supportive or nurse 
administered (without training) 
psychotherapy. Individual 
therapy, based in medical clinic 
unspecified. Analytic & 
supportive psychotherapy 
administered by therapist.  
Anxiety (GHQ & 
VAR) 
Depression (GHQ & 
VAR) 
35 
 
(Gift, Moore & Soeken, 1992) 
[45]  
USA 
Randomised  
Recruited from patient 
list of 3 private 
physicians 
26 (13) 
Control group required to 
sit quietly in room for same 
length of time as PMR 
Mean age 67 (36-86), 69.2% 
female, 100% white. COPD 
confirmed on spirometry 
according to ATS 
Progressive muscle relaxation, 
4x sessions on weekly basis, 
taped message to administer, 
venue physician’s office, group 
Anxiety (STAI) 36 
Emery, Schein, Hauck & 
MacIntyre, 1998) 
[46] 
USA 
Randomised controlled 
trial 
Recruited from local 
better breathers clubs, 
TV & newspaper 
advertising, word of 
mouth, physician 
referral 
73 (25, 23 & 25) 3 x groups, 
exercise, education & stress 
management (SM); 
education and SM and 
control.  Included education 
& SM and control group for 
review.  Control were 
waiting list,not to alter 
activity levels for 10 weeks. 
Mean age 66.6 (+6.5), 53% 
female, FEV1/FVC <.70, clinical 
symptoms of COPD for >6/12.  
Education and stress 
management comprising 16 
educational sessions and 10 
stress management classes.10 
week course.  
Anxiety (STAI, SCL-
90 anxiety subscale) 
 
Depression (CES-D, 
Affect-Balance Scale, 
SCL-90 depression 
subscale) 
 
Quality of Life (SIP) 
 
 
 
Table 2: Quality assessment of included studies 
Quality  
Criteria 
Study (reference) 
38 39 40 41 42 43 44 45 46 
Clear definition of aims 2 2 2 2 1 2 2 2 2 
Randomisation sequence 
(concealed) 
2 2 1 0 0 0 2 1 2 
Treatment allocation concealed 0 0 0 0 0 0 0 0 2 
Analysis of baseline characteristics 2 2 2 2 2 2 2 2 2 
Blinding of interventionists 
Blinding of participants 
Blinding of assessor 
0 
2 
0 
0 
2 
0 
0 
2 
2 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
2 
2 
0 
2 
0 
0 
2 
2 
Clear description of intervention 
Eligibility assessed? 
Where? 
What? 
How? 
Replicable? 
 
2 
1 
2 
2 
2 
 
2 
0 
2 
2 
2 
 
2 
0 
2 
2 
2 
 
2 
2 
2 
2 
2 
 
1 
2 
2 
2 
2 
 
2 
0 
2 
2 
2 
 
2 
1 
2 
2 
2 
 
2 
2 
2 
2 
2 
 
2 
2 
2 
2 
2 
Control group utilised 
Details of treatment of control 
group 
Comparability of groups 
2 
2 
 
2 
2 
2 
 
2 
2 
2 
 
2 
2 
2 
 
0 
0 
0 
 
0 
0 
0 
 
0 
2 
2 
 
2 
2 
2 
 
2 
2 
2 
 
2 
Attrition 1 2 0 1 1 1 1 2 2 
Power analysis done 0 2 0 0 0 0 0 0 0 
Effect size reported 0 2 0 0 0 0 0 0 0 
Confounding variables analysis 0 0 2 0 0 0 0 0 0 
Reporting of outcomes: 
Clear definition of outcomes 
Reliable measures of outcomes 
Results provided for all outcomes 
Details of timings of measures 
 
2 
2 
2 
2 
 
2 
2 
2 
2 
 
2 
2 
2 
2 
 
2 
2 
2 
2 
 
2 
2 
1 
2 
 
2 
1 
2 
2 
 
2 
2 
2 
2 
 
2 
2 
2 
2 
 
2 
2 
2 
2 
Missing values dealt with 0 2 0 0 0 0 0 0 0 
Appropriate statistical analysis 2 2 1 1 1 2 2 2 2 
Intention to treat analysis 0 0 0 0 0 0 0 0 0 
Total Score/56** 34 40 34 28 21 22 36 35 40 
0 = no / unknown   1 = partial              2 = yes 
 (Adapted from recommendations of quality criteria by Khan (2001) and Oakley et al (1995), Criteria 
for assessing quality of experimental research). [47; 48] 
Table 2
Groups 
compared 
 
Anxiety 
measures 
within groups 
Number 
of 
studies 
Total 
number of 
participants 
Combined 
effect size 
(r) 
Confidence 
interval 
Combined 
z 
Combined 
p 
Fail 
safe 
N 
Critical 
number 
for file 
drawer 
All studies 
(homogeneous) 
8 222 -0.273 -0.419 to -
0.141 
-3.927 0.00004 54 50 
Table  3: Summary of meta-analysis based on anxiety scores of patients exposed to 
psychological intervention. 
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Figure 1: Overview of search process, identification of studies and data extraction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Initial hits: 15, 772 (electronic 
database searches 
15, 629 excluded on title – 
irrelevant to current review 
question, including duplicate titles. 
143 titles included for review of 
abstract (excluding duplicates) 
21 included studies for full 
review 
122 excluded: 
Pulmonary rehabilitation (n=17) 
Other intervention (including medical) (n=39) 
No intervention (n=31) 
Other lung disease included (n=3) 
Not English (n=3) 
Existing review (n=11) 
Inappropriate outcomes (n=2) 
Descriptive article (e.g. editorial) (n=5) 
Unavailable doctoral thesis from overseas (n=2) 
Duplicate (n=9) 
Studies included in meta-analysis (n=9) 
13 excluded: 
Duplication of participants (n=2) 
No evaluation of intervention (n=2) 
Pulmonary rehabilitation (n=2) 
No psychological component (n=1) 
Inappropriate outcomes (n=1) 
Failure to obtain copy (n=3) 
Failure to report confirmation of diagnostic test (n=1) 
Co-morbidity of asthma and other medical conditions 
(n=1) 
1 study 
identified from 
reference list of 
included 
studies 
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